Why You Should Care About Implicit Bias as an Allergist-Immunologist and Ways We Can Address It

Samantha Jacobs; Kanwaljit Brar; Anna Nowak-Wegrzyn; Margee Louisias

doi:10.1016/j.jaip.2023.03.028

Why You Should Care About Implicit Bias as an Allergist-Immunologist and Ways We Can Address It

Samantha Jacobs
, Kanwaljit Brar
, Anna Nowak-Wegrzyn
, Margee Louisias

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	1718-1724
Number of pages	7
Journal	Journal of Allergy and Clinical Immunology: In Practice
Volume	11
Issue number	6
DOIs	https://doi.org/10.1016/j.jaip.2023.03.028
State	Published - Jun 2023
Externally published	Yes

Access to Document

10.1016/j.jaip.2023.03.028

Cite this

@article{99e2645659b648f181fc13dba7a3186e,

title = "Why You Should Care About Implicit Bias as an Allergist-Immunologist and Ways We Can Address It",

author = "Samantha Jacobs and Kanwaljit Brar and Anna Nowak-Wegrzyn and Margee Louisias",

note = "Funding Information: Conflicts of interest: K. Brar is an investigator for Incyte, Galderma, and Siolta; and has served on an advisory board for Incyte. M. Louisias received support from National Institutes of Health/National Heart, Lung, and Blood Institute Grant L30 HL143781, Brigham and Women's Hospital Minority Faculty Career Development Award, and a Robert A. Winn Diversity in Clinical Trials Career Development Award funded by Bristol Myers Squibb Foundation; is a consultant for RubiconMD; and has served on an advisory board for Sanofi. A. Nowak-Wegrzyn receives research support from Alladapt Immunotherapeutics and Regeneron; speaking fees from Nestle, Danone, and Thermo Fisher; and royalties from UpToDate; she serves as an associate editor for the Annals of Allergy, Asthma \& Immunology, director of the American Academy of Allergy, Asthma \& Immunology Board, and chair of the Medical Advisory Board of the International Food Protein-Induced Enterocolitis Syndrome Association. Funding Information: Conflicts of interest: K. Brar is an investigator for Incyte, Galderma, and Siolta; and has served on an advisory board for Incyte. M. Louisias received support from National Institutes of Health/National Heart, Lung, and Blood Institute Grant L30 HL143781, Brigham and Women{\textquoteright}s Hospital Minority Faculty Career Development Award, and a Robert A. Winn Diversity in Clinical Trials Career Development Award funded by Bristol Myers Squibb Foundation; is a consultant for RubiconMD; and has served on an advisory board for Sanofi. A. Nowak-Wegrzyn receives research support from Alladapt Immunotherapeutics and Regeneron; speaking fees from Nestle, Danone, and Thermo Fisher; and royalties from UpToDate; she serves as an associate editor for the Annals of Allergy, Asthma \& Immunology, director of the American Academy of Allergy, Asthma \& Immunology Board, and chair of the Medical Advisory Board of the International Food Protein-Induced Enterocolitis Syndrome Association. ",

year = "2023",

month = jun,

doi = "10.1016/j.jaip.2023.03.028",

language = "English",

volume = "11",

pages = "1718--1724",

journal = "Journal of Allergy and Clinical Immunology: In Practice",

issn = "2213-2198",

publisher = "American Academy of Allergy, Asthma and Immunology",

number = "6",

}

TY - JOUR

T1 - Why You Should Care About Implicit Bias as an Allergist-Immunologist and Ways We Can Address It

AU - Jacobs, Samantha

AU - Brar, Kanwaljit

AU - Nowak-Wegrzyn, Anna

AU - Louisias, Margee

N1 - Funding Information: Conflicts of interest: K. Brar is an investigator for Incyte, Galderma, and Siolta; and has served on an advisory board for Incyte. M. Louisias received support from National Institutes of Health/National Heart, Lung, and Blood Institute Grant L30 HL143781, Brigham and Women's Hospital Minority Faculty Career Development Award, and a Robert A. Winn Diversity in Clinical Trials Career Development Award funded by Bristol Myers Squibb Foundation; is a consultant for RubiconMD; and has served on an advisory board for Sanofi. A. Nowak-Wegrzyn receives research support from Alladapt Immunotherapeutics and Regeneron; speaking fees from Nestle, Danone, and Thermo Fisher; and royalties from UpToDate; she serves as an associate editor for the Annals of Allergy, Asthma & Immunology, director of the American Academy of Allergy, Asthma & Immunology Board, and chair of the Medical Advisory Board of the International Food Protein-Induced Enterocolitis Syndrome Association. Funding Information: Conflicts of interest: K. Brar is an investigator for Incyte, Galderma, and Siolta; and has served on an advisory board for Incyte. M. Louisias received support from National Institutes of Health/National Heart, Lung, and Blood Institute Grant L30 HL143781, Brigham and Women’s Hospital Minority Faculty Career Development Award, and a Robert A. Winn Diversity in Clinical Trials Career Development Award funded by Bristol Myers Squibb Foundation; is a consultant for RubiconMD; and has served on an advisory board for Sanofi. A. Nowak-Wegrzyn receives research support from Alladapt Immunotherapeutics and Regeneron; speaking fees from Nestle, Danone, and Thermo Fisher; and royalties from UpToDate; she serves as an associate editor for the Annals of Allergy, Asthma & Immunology, director of the American Academy of Allergy, Asthma & Immunology Board, and chair of the Medical Advisory Board of the International Food Protein-Induced Enterocolitis Syndrome Association.

PY - 2023/6

Y1 - 2023/6

UR - https://www.scopus.com/pages/publications/85153927256

U2 - 10.1016/j.jaip.2023.03.028

DO - 10.1016/j.jaip.2023.03.028

M3 - Article

C2 - 36972799

AN - SCOPUS:85153927256

SN - 2213-2198

VL - 11

SP - 1718

EP - 1724

JO - Journal of Allergy and Clinical Immunology: In Practice

JF - Journal of Allergy and Clinical Immunology: In Practice

IS - 6

ER -